Provided by Tiger Trade Technology Pte. Ltd.

DBV Technologies SA

13.90
+0.85006.51%
Post-market: 14.000.1001+0.72%18:36 EST
Volume:1.44M
Turnover:19.00M
Market Cap:557.86M
PE:-2.46
High:13.97
Open:13.28
Low:12.98
Close:13.05
52wk High:18.00
52wk Low:2.74
Shares:40.13M
Float Shares:22.56M
Volume Ratio:1.79
T/O Rate:6.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.6578
EPS(LYR):-5.8723
ROE:-234.14%
ROA:-77.29%
PB:10.55
PE(LYR):-2.37

Loading ...

Company Profile

Company Name:
DBV Technologies SA
Exchange:
NASDAQ
Establishment Date:
2002
Employees:
117
Office Location:
BAtiment IRO,107 Av. de la REpublique,Châtillon,Ile-de-France,France
Zip Code:
92320
Fax:
- -
Introduction:
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs includes vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, it develops Viaskin technology platform, a platform to potentially treat food allergy. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.

Directors

Name
Position
Daniel Tassé
Chief Executive Officer and Director
Michel de Rosen
Non-Executive Chairman of the Board
Adora Ndu
Director
Daniele Guyot Caparros
Director
Julie O'Neill
Director
Mailys Ferrère
Director
Michael J. Goller
Director
Philina Lee
Director
Ravi M. Rao
Director
Timothy E. Morris
Director

Shareholders

Name
Position
Daniel Tassé
Chief Executive Officer and Director
Virginie Boucinha
Chief Financial Officer
Pharis Mohideen
Chief Medical Officer